Search results
Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Price Target at $8.25
ETF DAILY NEWS· 1 day agoAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given a consensus recommendation of “Buy” by the four brokerages that are covering the stock, MarketBeat ...
Brokerages Set Axos Financial, Inc. (NYSE:AX) Price Target at $67.25
ETF DAILY NEWS· 1 day ago(NYSE:AX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the four...
Earnings Calendar, Analyst Estimates And Stocks To Watch
Investor's Business Daily· 14 hours agoWhen searching for the best stocks to buy and watch, look for companies with strong earnings growth...
Eden Research (LON:EDEN) Stock Price Up 8.8%
ETF DAILY NEWS· 1 day agoShares of Eden Research plc (LON:EDEN – Get Free Report) rose 8.8% on Monday . The company traded as high as GBX 4.65 ($0.06) and last traded at GBX 4.65 ($0.06). Approximately 286,613 shares ...
The Dow Needs to Replace Boeing, Intel, Salesforce, and Cisco. 4 Stocks We Recommend Instead.
Barrons.com· 5 days agoThe stock is up 44.5% this year. Switch Intel with Micron Technology It has been a terrible year for...
What To Expect in the Markets This Week
Investopedia via Yahoo Finance· 2 days agoInvestors will get more insight into the artificial intelligence landscape as investor darling Nvidia hosts its shareholder meeting and Micron Technology
Dow Jones, Nasdaq, S&P 500 weekly preview: Markets brace for Micron earnings By Investing.com
Investing.com· 19 hours agoThe S&P 500 dipped on Friday as shares of market darling Nvidia (NASDAQ:NVDA) fell for the second...
These Stocks Are Moving the Most Today
Barrons.com· 7 days agoNvidia passes Microsoft to become the largest company by market value, analysts raise their price targets on shares of Micron Technology
Micron, inflation data, and the debate will rock markets this week
TheStreet via Yahoo Finance· 2 days agoMicron's earnings for the fiscal third quarter are estimated at 38 cents a share, up from a loss of...
Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 1 day agoStockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on ...
